Market Overview

Novo Nordisk Posts 35% Rise In Q3 Profit, Lifts 2012 Forecast

Share:
Related NVO
Eli Lilly's Risks Could Be Underappreciated, Goldman Sachs Says In Downgrade
Novo Nordisk Confirms Bid For Ablynx But Faces Rejection
FDA launches new program to boost transparency of clinical data used to support approvals (Seeking Alpha)

Novo Nordisk A/S (NYSE: NVO) reported a 35% rise in its third-quarter net profit and lifted its full-year earnings forecast.

Novo Nordisk's quarterly net profit surged to DKK5.67 billion, from DKK4.20 billion, in the year-ago period. However, analysts were expecting a profit of DKK5.27 billion.

Novo Nordisk shares closed at $161.29 yesterday.

Posted-In: profitEarnings News Guidance

 

Related Articles (NVO)

View Comments and Join the Discussion!